封面
市場調查報告書
商品編碼
1485956

全球脊椎側彎管理市場 - 全球產業分析、規模、佔有率、成長、趨勢、預測 (2031) - 依產品類型、依年齡層、依分銷管道、依地區

Scoliosis Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日期: | 出版商: Fairfield Market Research | 英文 273 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

由於脊椎側彎盛行率不斷上升以及矯正器技術的進步,全球脊椎側彎管理市場規模正在顯著成長。在現有的各種產品中,頸胸腰骶矯正器(CTLSO)和胸腰骶矯正器(TLSO)對於治療各種類型的脊椎側彎非常重要。

CTLSO 支架是兩件式結構,帶有金屬頸椎附件,可支撐頸部和背部並防止脊椎移動。主要用於治療上背部畸形和頸部問題。當這些支架被移除時,脊椎的彎曲可能會恢復到原來的位置,並隨著時間的推移而惡化。

脊椎側彎在男性中比女性更常見,可分為隨著年齡的增長而彎曲消失的脊椎側彎和脊椎側彎逐漸進展並需要支架來減緩進展的脊椎側彎。

青少年脊椎側彎常見於 5 至 9 歲的兒童。這種類型的脊椎側彎往往生長迅速且呈進展性,需要使用支架來加強脊椎並減緩彎曲的進展。應每 12 至 18 個月調整一次支架,以適應孩子的成長和曲率變化。

青少年脊椎側彎發生在 10 至 18 歲之間。確切原因尚不清楚,但被認為是由於荷爾蒙不平衡、生長不對稱、肌肉不平衡等造成的。物理治療和治療用於10至20度之間的彎曲,支架用於20至40度之間的彎曲以防止進展。為了獲得有效的效果,必須在一天中的大部分時間佩戴這些牙套。

本報告調查了全球脊椎側彎管理市場,並依產品類型、年齡層、分銷管道、地區以及進入該市場的公司的競爭趨勢提供了市場概述。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 杵分析

第 3 章2018-2031 年全球脊椎側彎管理市場展望

  • 2018-2031 年全球脊椎側彎管理市場展望(依產品類型、價值(十億美元))
  • 2018-2031 年全球脊椎側彎管理市場展望(依年齡層)、價值(十億美元)
  • 2018-2031 年全球脊椎側彎管理市場展望,依通路劃分,價值(十億美元)
  • 2018-2031 年全球脊椎側彎管理市場展望(依地區、價值(十億美元))

第 4 章北美脊椎側彎管理市場展望,2018-2031

第 5 章歐洲脊椎側彎管理市場展望,2018-2031

第 6 章亞太地區脊椎側彎管理市場展望,2018-2031

第 7 章拉丁美洲脊椎側彎管理市場展望,2018-2031

第 8 章中東與非洲脊椎側彎管理市場展望,2018-2031 年

第九章競爭態勢

  • 2023 年公司市佔率分析
  • 競爭儀表板
  • 公司簡介
    • Aspen Medical Products
    • DJO Global
    • Ottobock
    • Horton's Orthotics & Prosthetics
    • Boston O&P
    • TRULIFE.
    • Bauerfeind AG
    • Spinal Technology Inc.
    • 其他

第 10 章附錄

簡介目錄

The global scoliosis management market has experienced significant growth due to the increasing prevalence of scoliosis and advancements in brace technology. Among the various products available, Cervical Thoracic Lumbar Sacral Orthosis (CTLSO) and Thoracolumbosacral Orthosis (TLSO) braces are crucial in managing different types of scoliosis.

Key Products in Scoliosis Management

Cervical Thoracic Lumbar Sacral Orthosis (CTLSO) Braces

CTLSO braces are designed with a two-piece structure and a metal cervical attachment that supports the neck and back region, preventing spine movement. They are primarily used to treat upper back deformities and neck issues. If these braces are removed, the spinal curve may return to its original position and could worsen over time.

Thoracolumbosacral Orthosis (TLSO) Braces

TLSO braces are used for the mid to lower spine area. These braces are customized based on the degree of the spinal curve and are prescribed for children with curvature degrees between 20 and 40. The pads in the braces provide pressure to slow down scoliosis progression, allowing for partial movement and accommodating body growth. If the curvature does not increase while wearing the brace, patients can potentially avoid spinal fusion surgery.

Lumbosacral Orthosis (LSO) Braces

LSO braces cover all or part of the lumbar region and are used to correct the lateral curve of the spine. These braces compress the abdomen and lumbar spine tightly, providing posture support to the spine. The pressure applied by the braces can be adjusted through laces or the back of the belt.

Scoliosis Types and Management

Infantile Scoliosis

Infantile scoliosis affects infants between birth and four years of age, presenting as an abnormal curve shaped like an S or C. This condition is more common in males than females and falls into two categories: those whose curvature disappears with growth and those whose curvature progresses and requires bracing to slow its progression.

Juvenile Scoliosis

Juvenile scoliosis is diagnosed in children aged five to nine years. This type of scoliosis tends to grow faster and becomes progressive, necessitating the use of braces to strengthen the spine and restrain curvature progression. Braces need to be adjusted every 12 to 18 months to accommodate the child's growth and changing curvature.

Adolescent Scoliosis

Adolescent scoliosis occurs between the ages of 10 and 18 years. Although the exact cause is unknown, it may be due to hormonal imbalances, asymmetrical growth, and muscle imbalance. Physical therapies and treatments are administered for curves between 10 and 20 degrees, while braces are used for curves between 20 and 40 degrees to prevent progression. These braces need to be worn continuously for most of the day to achieve effective results.

Market Dynamics

Growth Drivers

The global scoliosis management market is primarily driven by the high prevalence of the disease, the widespread adoption of braces, and technological advancements in tracking devices that monitor patient health. Additionally, the increasing demand for non-invasive therapies is expected to drive market growth for scoliosis braces.

Challenges

Despite the growth prospects, several challenges persist. The braces need to be worn for most of the day, which can cause stiffness, skin irritation, and rashes. Additionally, the compression of the chest wall and abdomen can lead to breathing problems, affecting oxygen flow and pulmonary functions.

Market Outlook

The global scoliosis management market is expected to continue growing, driven by less expensive braces and increasing awareness among people. These factors are anticipated to further propel market growth over the forecast period.

Key Market Players Include:

  • Aspen Medical Products
  • DJO Global
  • Ottobock
  • Horton's Orthotics & Prosthetics
  • Boston O&P
  • TRULIFE.
  • Bauerfeind AG
  • Spinal Technology Inc.
  • Fited
  • Wellinks, Inc.
  • Others.

Global Scoliosis Management Market Segmentation:

By Product Type:

  • Cervical Thoracic Lumbar
  • Thoracolumbosacral orthosis
  • Lumbosacral Orthosis

By Age Group:

  • Infantile Scoliosis
  • Juvenile Scoliosis
  • Adolescent Scoliosis

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online sales

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Scoliosis Management Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. PESTLE Analysis

3. Global Scoliosis Management Market Outlook, 2018 - 2031

  • 3.1. Global Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Cervical Thoracic Lumbar
      • 3.1.1.2. Thoracolumbosacral orthosis
      • 3.1.1.3. Lumbosacral Orthosis
  • 3.2. Global Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Infantile Scoliosis
      • 3.2.1.2. Juvenile Scoliosis
      • 3.2.1.3. Adolescent Scoliosis
  • 3.3. Global Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospital Pharmacies
      • 3.3.1.2. Retail Pharmacies
      • 3.3.1.3. Online sales
  • 3.4. Global Scoliosis Management Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Scoliosis Management Market Outlook, 2018 - 2031

  • 4.1. North America Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Cervical Thoracic Lumbar
      • 4.1.1.2. Thoracolumbosacral orthosis
      • 4.1.1.3. Lumbosacral Orthosis
  • 4.2. North America Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Infantile Scoliosis
      • 4.2.1.2. Juvenile Scoliosis
      • 4.2.1.3. Adolescent Scoliosis
  • 4.3. North America Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospital Pharmacies
      • 4.3.1.2. Retail Pharmacies
      • 4.3.1.3. Online sales
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Scoliosis Management Market Outlook, 2018 - 2031

  • 5.1. Europe Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Cervical Thoracic Lumbar
      • 5.1.1.2. Thoracolumbosacral orthosis
      • 5.1.1.3. Lumbosacral Orthosis
  • 5.2. Europe Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Infantile Scoliosis
      • 5.2.1.2. Juvenile Scoliosis
      • 5.2.1.3. Adolescent Scoliosis
  • 5.3. Europe Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospital Pharmacies
      • 5.3.1.2. Retail Pharmacies
      • 5.3.1.3. Online sales
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Scoliosis Management Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Cervical Thoracic Lumbar
      • 6.1.1.2. Thoracolumbosacral orthosis
      • 6.1.1.3. Lumbosacral Orthosis
  • 6.2. Asia Pacific Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Infantile Scoliosis
      • 6.2.1.2. Juvenile Scoliosis
      • 6.2.1.3. Adolescent Scoliosis
  • 6.3. Asia Pacific Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospital Pharmacies
      • 6.3.1.2. Retail Pharmacies
      • 6.3.1.3. Online sales
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Scoliosis Management Market Outlook, 2018 - 2031

  • 7.1. Latin America Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Cervical Thoracic Lumbar
      • 7.1.1.2. Thoracolumbosacral orthosis
      • 7.1.1.3. Lumbosacral Orthosis
  • 7.2. Latin America Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Infantile Scoliosis
      • 7.2.1.2. Juvenile Scoliosis
      • 7.2.1.3. Adolescent Scoliosis
  • 7.3. Latin America Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospital Pharmacies
      • 7.3.1.2. Retail Pharmacies
      • 7.3.1.3. Online sales
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Scoliosis Management Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Cervical Thoracic Lumbar
      • 8.1.1.2. Thoracolumbosacral orthosis
      • 8.1.1.3. Lumbosacral Orthosis
  • 8.2. Middle East & Africa Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Infantile Scoliosis
      • 8.2.1.2. Juvenile Scoliosis
      • 8.2.1.3. Adolescent Scoliosis
  • 8.3. Middle East & Africa Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospital Pharmacies
      • 8.3.1.2. Retail Pharmacies
      • 8.3.1.3. Online sales
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2023
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. Aspen Medical Products
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Product Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. DJO Global
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Product Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. Ottobock
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Product Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Horton's Orthotics & Prosthetics
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Product Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. Boston O&P
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Product Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. TRULIFE.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Product Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. Bauerfeind AG
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Product Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. Spinal Technology Inc.
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Product Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Others
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Product Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development

10. Appendix

  • 10.1.Research Methodology
  • 10.2.Report Assumptions
  • 10.3.Acronyms and Abbreviations